C14 Marked Key Compound Preparation Technology Conquer-China Chemical News (Sinochem New Net)
Release time:
2019-04-15
C14 Marked Key Compound Preparation Technology Conquer Author: Wu Ban Source: China Chemical News March 26, 2019 Website; http://www.ccin.com.cn/detail/c18866c562abbac1ba4154d0ca9e214c/news中化新网讯3月20日,江苏省江阴国家高新区发布了一项重点创新成果:该区无锡贝塔医药科技有限公司攻克了C14标记关键化合物制备和标记技术,成功开发出用于胃幽门螺旋杆菌感染诊断
C14 Labeling Key Compound Preparation Technology
Author: Wu BanSource: China Chemical News March 26, 2019
Website:http://www.ccin.com.cn/detail/c18866c562abbac1ba4154d0ca9e214c/news
Sinochem New Network NewsOn March 20, Jiangyin National High-tech Zone in Jiangsu Province released a key innovation: Wuxi Beta Pharmaceutical Technology Co., Ltd. in the zone has conquered the preparation and labeling technology of C14 labeled key compounds, and successfully developed the key shortage raw materials urea-14C and urea-13C for diagnosis of Helicobacter pylori infection, which can meet the research and development needs of new drugs and new pesticides in China.
At present, Wuxi Beta's self-developed for pharmaceutical, clinical and environmental research.C14 and other marks have provided more than 10 successful marks for new drugs for Sichuan Kelun Pharmaceutical Research Institute, Jiangsu Hengrui Pharmaceutical, Nanjing Shenghe Pharmaceutical and other leading enterprises in new pharmaceutical research and development, as well as leading pesticide research and development enterprises in Qingdao Qingyuan, which are more efficient and less expensive than similar foreign technologies.
According to reports, isotope labeling is an important aspect of the peaceful use of nuclear energy, and it is also an important part of serving medicine, pesticides, environmental protection industries, the national economy and people's lives. For a long time, due to the blockade of foreign technology, China has been used for pharmaceutical, clinical and environmental research.C14 and other marks, the vast majority need to be sent abroad to do, expensive, long cycle, become the bottleneck of development.
Website:http://www.ccin.com.cn/detail/c18866c562abbac1ba4154d0ca9e214c/news
Related News
Tel.：0510-81695383
E-mail：chengcaihong@beitalab.com
Fax：0510-81602153
Add：70 Dongsheng West Road, Jiangyin City, Jiangsu Province
Postal Code: 214437
Copyright©2024 Wuxi Beita Pharmatech Co., Ltd. Business License
